Merav Lidar

4.5k total citations
142 papers, 2.7k citations indexed

About

Merav Lidar is a scholar working on Molecular Biology, Rheumatology and Immunology. According to data from OpenAlex, Merav Lidar has authored 142 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 51 papers in Rheumatology and 42 papers in Immunology. Recurrent topics in Merav Lidar's work include Inflammasome and immune disorders (66 papers), Spondyloarthritis Studies and Treatments (22 papers) and Systemic Lupus Erythematosus Research (18 papers). Merav Lidar is often cited by papers focused on Inflammasome and immune disorders (66 papers), Spondyloarthritis Studies and Treatments (22 papers) and Systemic Lupus Erythematosus Research (18 papers). Merav Lidar collaborates with scholars based in Israel, Italy and United States. Merav Lidar's co-authors include Avi Livneh, Pnina Langevitz, Iris Eshed, Yehuda Shoenfeld, Ilan Ben‐Zvi, Olga Feld, Yackov Berkun, Elon Pras, Shai Padeh and Dvora Aharoni and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Merav Lidar

135 papers receiving 2.7k citations

Peers

Countries citing papers authored by Merav Lidar

Since Specialization

Citations

This map shows the geographic impact of Merav Lidar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merav Lidar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merav Lidar more than expected).

Fields of papers citing papers by Merav Lidar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merav Lidar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merav Lidar. The network helps show where Merav Lidar may publish in the future.

Co-authorship network of co-authors of Merav Lidar

This figure shows the co-authorship network connecting the top 25 collaborators of Merav Lidar. A scholar is included among the top collaborators of Merav Lidar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merav Lidar. Merav Lidar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical course and prognostic disparities of pyoderma gangrenosum based on underlying disease: A long-term comparative study in 124 patients 2025 ·Annales de Dermatologie et de Vénéréologie ·(unknown), Seth J. Baum, Amit Druyan, Richard Mansour, Aviv Barzilai, Merav Lidar	1
2	Can a virtual multi-centre multi-disciplinary discussion improve the diagnosis and management of interstitial lung disease? A retrospective cohort study across multiple institutions 2025 ·BMJ Open ·(unknown), (unknown), (unknown), Inbal Shafran, Edith M. Marom, Efrat Ofek, Marina Perelman, Merav Lidar, (unknown), (unknown), Michael Peled, Liran Levy	0
3	Early methotrexate treatment for psoriatic arthritis prevention in psoriasis patients – A retrospective cohort study 2024 ·Joint Bone Spine ·(unknown), Merav Lidar, (unknown), A Barzilai, (unknown), Amit Druyan	2
4	Screening for Fabry’s disease in a high-risk subpopulation of FMF 2022 ·European journal of medical research ·(unknown), Ilan Ben‐Zvi, Merav Lidar, Avi Livneh	0
5	Systematic Review and Meta-Analysis of Tocilizumab Therapy versus Standard of Care in over 15,000 COVID-19 Pneumonia Patients during the First Eight Months of the Pandemic 2021 ·International Journal of Environmental Research and Public Health ·Naim Mahroum, ‬‬‬‬Abdulla Watad, Charlie Bridgewood, (unknown), (unknown), (unknown), Rola Khamisy‐Farah, Raymond Farah, Omer Gendelman, Merav Lidar, Yehuda Shoenfeld, Howard Amital, Jude Dzevela Kong, Jian Wu, Nicola Luigi Bragazzi, Dennis McGonagle	18
6	The risk for severe COVID 19 in patients with autoimmune and/or inflammatory diseases: First wave lessons 2020 ·Dermatologic Therapy ·Amit Druyan, Merav Lidar, Michal Brodavka, Itzchak Levy, Aviv Barzilai, Felix Pavlotsky	14
7	Systemic sclerosis is an independent risk factor for ischemic heart disease, especially in patients carrying certain antiphospholipid antibodies: A large cross-sectional study 2020 ·European Journal of Internal Medicine ·‬‬‬‬Abdulla Watad, Dennis McGonagle, Nicola Luigi Bragazzi, Giovanni Damiani, Doron Comaneshter, Merav Lidar, Arnon D. Cohen, Howard Amital	4
8	Post-traumatic arthritis of the sacroiliac joints mimicking inflammatory sacroiliitis: analysis of consecutive computed tomography examinations 2020 ·Clinical Radiology ·(unknown), Amir Herman, Merav Lidar, Iris Eshed	2
9	Infliximab and Pyoderma Gangrenosum in IBD 2019 ·JCR Journal of Clinical Rheumatology ·(unknown), (unknown), Merav Lidar	0
10	A high and equal prevalence of the Q703K variant in NLRP3 patients with autoinflammatory symptoms and ethnically matched controls. 2018 ·PubMed ·Merav Lidar, (unknown), Yael Shinar, Haike Reznik‐Wolf, Avi Livneh, (unknown), Rinat Cohen, Yackov Berkun, Philip J. Hashkes, Hagit Peleg, Aharon Kessel, Gleb Slobodin, Michael Rozenbaum, (unknown), Elon Pras	5
11	Decrease in 14-3-3η protein levels is correlated with improvement in disease activity in patients with rheumatoid arthritis treated with Tofacitinib 2018 ·Pharmacological Research ·Ora Shovman, Boris Gilburd, ‬‬‬‬Abdulla Watad, Howard Amital, Pnina Langevitz, Nicola Luigi Bragazzi, Mohammad Adawi, María Dolores Pérez, Merav Lidar, (unknown), (unknown), (unknown), A. Marotta, Yehuda Shoenfeld	11
12	Colchicine-free remission in familial Mediterranean fever: featuring a unique subset of the disease-a case control study 2014 ·Orphanet Journal of Rare Diseases ·Ilan Ben‐Zvi, (unknown), Olga Feld, Merav Lidar, Shaye Kivity, Avi Livneh	22
13	Erysipelas‐like erythema as the presenting feature of familial Mediterranean fever 2012 ·Journal of the European Academy of Dermatology and Venereology ·Merav Lidar, (unknown), Aviv Barzilai, Olga Feld, Nurit Zaks, Avi Livneh, Pnina Langevitz	22
14	Attempts at suppression of amyloidogenesis in a mouse model by a variety of anti-inflammatory agents 2012 ·Autoimmunity Reviews ·Shmuel Shtrasburg, Mordechai Pras, E. Rabinovich, Rivka Gal, Avi Livneh, Merav Lidar	2
15	Role of the R92Q TNFRSF1A mutation in patients with familial Mediterranean Fever 2010 ·Arthritis Care & Research ·Dina Marek‐Yagel, Yackov Berkun, Shai Padeh, Merav Lidar, Yael Shinar, Ifat Bar-Joseph, Haike Reznik‐Wolf, Pnina Langevitz, Avi Livneh, Elon Pras	13
16	Familial Mediterranean Fever in the First Two Years of Life: A Unique Phenotype of Disease in Evolution 2010 ·The Journal of Pediatrics ·Shai Padeh, Avi Livneh, Elon Pras, Yael Shinar, Merav Lidar, Olga Feld, Yackov Berkun	44
17	P wave dispersion in familial Mediterranean fever 2010 ·Rheumatology International ·Naomi Nussinovitch, Avi Livneh, (unknown), Moshe Nussinovitch, Benjamin Volovitz, Merav Lidar, Udi Nussinovitch	15
18	MEFV mutation carriage in Israeli Jewish individuals from ethnicities with low risk for familial Mediterranean fever 2009 ·Journal of Human Genetics ·Olga Feld, Avi Livneh, Yael Shinar, Yackov Berkun, Merav Lidar	4
19	Unique spectrum of MEFV mutations in Iranian Jewish FMF patients clinical and demographic significance 2007 ·Lara D. Veeken ·Yael Shinar, Iryna Kuchuk, (unknown), (unknown), Merav Lidar, Pnina Langevitz, Avi Livneh	6
20	Effect of Enalapril and Nifedipine on Orthostatic Hypotension in Older Hypertensive Patients 2000 ·Journal of the American Geriatrics Society ·(unknown), Rita Rachmani, Zohar Levi, David Brosh, Merav Lidar, Mordchai Ravid	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact